Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Biogen, Inc. (NQ: BIIB)
238.07 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:26 AM EDT, Jun 27, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 238.07
Bid (Size) 238.00 (1)
Ask (Size) 239.20 (9)
Prev. Close 238.07
Today's Range 238.07 - 238.07
52wk Range 216.12 - 388.67
Shares Outstanding 211,007,945
Dividend Yield N/A
Performance
YTD
-21.86%
-21.86%
1 Month
+5.56%
+5.56%
3 Month
+3.53%
+3.53%
6 Month
-19.34%
-19.34%
1 Year
-18.45%
-18.45%
Top News
More News
Biogen to Present New Safety and Efficacy Data on Biosimilars and Estimates 1.8 Billion Euros in Savings for the European Healthcare System in 2019
Biogen Inc. (Nasdaq: BIIB) today announced that it will present new data at the European Congress of Rheumatology (EULAR) 2019 in Madrid, Spain (June 12-15). The abstracts include real-world data from... Read More
from GlobeNewswire News Releases
Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million
Nightstar acquisition further bolsters Biogen’s pipeline with the addition of two mid- to late-stage clinical assets as well as preclinical programs Read More
from GlobeNewswire News Releases
More News
Read More
Nasdaq 100 Movers: NTES, BIIB
category Stocks
from Market News Video
Notable Friday Option Activity: COF, BIIB, HUM
category Stocks
from Market News Video
Biogen Inc Has Returned 26.0% Since SmarTrend Recommendation (BIIB)
from Comtex SmarTrend® News Briefs
Biotech Stocks Heat Up, Driving ETF Gains
category VRTX , CELG , INCY , and 11 more.
from ETF Trends
Notable ETF Outflow Detected - IBB, GILD, BIIB, VRTX
category ETFs
from ETF Channel
Shares of cancer-therapy companies skyrocket after Pfizer acquisition news
category Biotechnology , NVO , TPTX , and 19 more.
from MarketWatch
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
category GILD , BIIB , PFE , and 5 more.
from Motley Fool
Notable Thursday Option Activity: REGN, BIIB, GRMN
category Stocks
from Market News Video
Biogen Inc Has Returned 26.8% Since SmarTrend Recommendation (BIIB)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.